Oral terbinafine liver disease — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Advise not to use oral terbinafine without medical assessment because liver disease is relevant
Oral terbinafine can cause hepatotoxicity and should be assessed carefully in liver disease. In this scenario, the pharmacist should prioritise safe supply, appropriate counselling and timely referral or clarification where needed. This is the single best answer because the other options would either delay assessment, ignore a clinically significant risk, or create an unsafe legal or professional outcome.
Reference: BNF; MEP